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Summary: Oxidatively modified low density lipoproteins are thought to play an important role in the generation
of macrophage-derived foam cells in early atherosclerotic lesions. Cultured endothelial cells, monocytes,
macrophages and smooth muscle cells can modify low density lipoproteins, either by a free radical mechanism
or by the action of lipoxygenases. Previous studies demonstrated that activated human polymorphonuclear
leukocytes can oxidize low density lipoprotein lipids. Stimulation of the cells with phorbol 12-myristate 13-
acetate resulted in an increase both in Superoxide anion production and in low density lipoprotein oxidation.
The present results show that the oxidative modification of low density lipoproteins by human polymorpho-
nuclear leukocytes can be inhibited by Superoxide dismutase but not by the lipoxygenase inhibitor, (5,8,11,14)-
eicosatetraynoic acid. The low density lipoproteins oxidized by polymorphonuclear leukocytes were recognized
by the scavenger receptor of macrophages (P 388 cell line). It is proposed that the Superoxide anion is an
important factor in the the oxidative modification of low density lipoproteins induced by polymorphonuclear
leukocytes, and that under conditions of increased oxidative metabolism in vivo, polymorphonuclear leukocytes
can contribute to foam cell formation by a scavenger receptor-dependent process at lesion sites.
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multifactorial. Hypercholesterolaemia is widely ac- peroxidation products (8, 9). It has been proposed
cepted as one of the major risk factors contributing that the oxidative modification of low density lipo-
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') This work is part of the doctoral thesis of A. Brandes. droperoxides (17, 18). However, polymorphonuclear
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leukocytes also contain the 15-lipoxygenase enzyme
(19). Modification of the apolipoprotein B-100 by
neutrophil elastase has also been reported and it was
suggested that such elastase-modified low density
lipoproteins may contribute to foam cell formation
(20). However, these elastase-modified low density
lipoproteins are recognized by the low density lipo-
protein receptor and not by the scavenger receptor of
macrophages.
The present study was designed to clarify the mech-
anism of the oxidative modification of low density
lipoproteins by polymorphonuclear leukocytes and to
determine whether such modified low density lipopro-
teins are recognized by the scavenger receptor of
macrophages.
Materials and Methods
Preparatioh'of cells
Human polymorphonuclear leukocytes were isolated by density
gradient centrifugation (21) using a 4 + 1 (by vol.) mixture of
neutrophil isolation medium (NIM; Los Alamos Diagnostics,
Los Alamos, NM, USA) and Lymphoprep (Nycomed, Oslo,
Norway). Five ml venous blood anticoagulated with 10000 U/l
Na-heparin were layered over an equal volume of the NIM/
Lymphoprep mixture in sterile plastic tubes and centrifuged at
400 g for 40 min at 4 °C. Polymorphonuclear leukocytes were
removed by aspiration and washed 3 times with Hank's Bal-
anced Salt Solution (G1BCO, Paisley, UK). After the last wash
erythrocytes were lysed for 30—60 seconds with H2O and the
polymorphonuclear leukocyte suspension was washed again
with Hank's Balanced Salt Solution. The resulting pellet was
resuspended in serum-free Ham's F-10 medium (GIBCO, Pais^
ley, UK) containing 100 χ 103 U/l penicillin and 100 mg/1
streptomycin. Cell numbers and purity were determined with
an automatic cell counter (Technicon H l, Bayer Diagnostic
Co, Tarrytown, NY, USA) using the differential counting mode.
Cell preparations contained 98% polymorphonuclear leuko-
cytes, 2% lymphocytes, but no contamination by monocytes.
Unless indicated otherwise, cell numbers were adjusted to
3 χ 109/1 and plated in serum-free Ham's F-10 medium
(GIBCO, Paisley, UK) on 35 mm plastic cell culture dishes
(Nunc, Roskilde, DK). Cells were allowed to settle for 15 min,
then used for modification studies without further washing.
For degradation experiments the murine macrophage cell line
P 388 D (Paesel-Lorey GmbH, Frankfurt, Germany) was used.
Cells were plated on 35 mm culture dishes in RPMI 1640
medium (GIBCO, Paisley, UK) containing fetal calf serum
(volume fraction 0.1) and antibiotics (100 χ ΙΟ3 U/l penicillin,
100 mg/1 streptomycin). At confluence, cells were washed twice
with serum-free RPMI 1640 medium, then used for degradation
studies with low density lipoproteins.
Isolat ion and modif icat ion of low density lipo-
proteins
Low density lipoproteins (d = 1.019 -1.063 kg/1) were isolated
by ultracentrifugation from the plasma of healthy donors using
an established protocol (22). After isolation, low density lipo-
proteins were extensively dialysed against a Tris-HCl buffer
(5 mmol/1, pH 7.4) containing 1 mmol/1 EDTA. The cholesterol,
triacylglycerol, phospholipid and protein content of the low
density lipoprotein preparation were determined. Low density
lipoproteins were labelled with 125I by the iodine monochloride
method (23). Before modification, low density lipoproteins were
dialysed against a nitrogen-saturated Tris-HCl buffer (5 mmol/1,
pH 7.4) free of EDTA and diluted to a protein concentration
of 0.1 g/l. Incubations were performed for 24 h in 35-rrirh culture
dishes with serum-free Ham's F-10 medium (2 ml) in the pres-
ence of either polymorphonuclear - leukocytes or 10 μιηοΐ/ΐ
CuSO4 (37 °C, 95% O2, 5% CO2). In some incubations, cells
were activated with 6.25 nmol/1 phorbol 12-myristate 13-acetate
(Sigma Chemical Co., St. Louis, MO, USA). Cell integrity was
monitored visually by phase contrast light microscopy and
trypan blue exclusion. The protease inhibitor, aprotinin (0.1
g/l) (Sigma Chemical Co., St. Louis, MO, USA), was added to
the incubations to prevent non-specific degradation of the apo-
lipoprotein B-100. Low density lipoproteiris were acetylated
with acetic anhydride and saturated sodium acetate as described
(24).
Analytical techniques
The extent of lipid peroxidation in the modified low density
lipoproteins was quantified by measuring thiobarbituric acid-
reactive substances, and expressed as malondialdehyde equiv-
alents (8). The electrophoretic mobility of the modified low
density lipoproteins was tested by agarose gel electrophoresis
(25) using a commercially available kit (Lipidophor, Immuno
GmbH, Vienna, Austria). The ability of macrophages to de-
grade the modified low density lipoproteins was determined as
follows: 10 μg of 125I-labelled low density lipoproteins (native
or modified) were added to macrophages in 35-mm cell culjture
dishes in 1 ml of RPMI 1640, and incubated at 37 °C for 5 h.
The medium was then removed and analysed for non-iodide
trichloroacetic acid-soluble radioactivity as described elsewhere
(24). Control dishes without macrophages were run and specific
degradation was calculated by subtracting these cell-free con-
trols from incubations in the presence of macrophages. Com-
petition experiments were performed using a tenfold excess of
unlabelled low density lipoproteins.
Protein was determined by the Lowry method (26) using serum
albumin as a standard. Superoxide anion production was de-
termined by measuring Superoxide dismutase2) inhibitable cy-
tochrome c reduction, using the end point procedure described
by Marken et al. (27). Cholesterol, triacylglycerols and phos-
pholipids were determined by established standard methods in
our routine clinical chemistry laboratory.
Inhibi tors
5,8,11,14-Eicosatetraynoic acid was purchased from Cayman
Chemical, Ann Arbor, MI, USA. Butylated hydroxytoluene,
mannitol, catalase2) and Superoxide dismutase were from
Sigma, Chemical Co., St. Louis, MO, USA. Butylated hydroxy-
toluene and eicosatetraynoic acid were dissolved in ethanol
while all other inhibitors were dissolved in Ham's F-10 medium
(GIBCO, Paisley, UK). Inhibitors were added to the incuba-
tions in 20 μΐ aliquots before the start of incubations. Control
dishes were incubated under identical conditions but in the
absence of inhibitors. Controls without cells or copper ions
were also run. Superoxide dismutase was heat inactivated by
incubating the enzyme at 90 °C for 10 min in a shaking water
bath.
Statistics
Statistical analysis was performed using the Wilcoxon test for
matched pairs.
°
2) Enzymes
Catalase: Hydrogen-peroxide: hydrogen-peroxide oxidore-
ductase (EC 1.11.1.6)
Superoxide dismutase: Superoxide: Superoxide oxidoreduc-
tase(EC 1.15.1.1)
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 11
Wieland et al.: Modification of LDL by leukocytes 727
40
20
υ *ο \
r I
.Έ ευσ β,
" χ
•c Je3 0)
~ -ο
£ σ 10
2 '"5
« §
£ Ι
p<0.05
p<0.05
ι 1
p<0.05
l 1
LDL
incubated
with CuSO,
LDL
incubated
with
activated
cells
LDL LDL
incubated incubated
with wi thout
cells cells
Fig. 1. Oxidation of low density lipoprolein (LDL) preparations (n = 5) by copper ions, polymorphonuclear leukocytes and
activated polymorphonuclear leukocytes. Cells were activated with phorbol 12-myristate 13-acetate. Experimental condi-
tions as described in Materials and Methods.
Results
Incubation of low density lipoproteins (protein con-
centration 0.1 g/1) for 24 h in the presence of freshly
isolated human polymorphonuclear leukocytes
(3 χ 106 cells per dish) produced 16.0 ± 6.9 mmol
malondialdehyde equivalents per kg low density lip-
oprotein protein (n = 5), whereas control incubations
without cells produced 4.2 ±1.4 mmol malondialde-
hyde equivalents per kg low density lipoprotein
(n = 5; p < 0.05). Lipid peroxidation was dependent
on the cell number: 5 χ 105 polymorphonuclear leu-
kocytes yielded 7 mmol malondialdehyde equivalents
per kg low density lipoprotein protein, whereas
1 χ 106 cells yielded 9.5 mmol malondialdehyde
equivalents per kg low density lipoprotein. Addition
of 6.25 nmol/1 phorbol 12-myristate 13-acetate to
3 χ 106 polymorphonuclear leukocytes caused a fur-
ther statistically significant increase of peroxidation
of low density lipoprotein lipids (21.7 ± 3.4 mmol
malondialdehyde equivalents per kg low density lipo-
protein protein; n = 5; ρ < 0.05) (fig. 1). Acceleration
of lipid peroxidation by activated cells was apparent
beyond 6 hours of incubation (fig. 2). The enhanced
oxidation of low density lipoprotein lipids by acti-
Fig. 2. Time course of thiobarbituric acid reactive substance formation during incubation of a low density lipoprotein (LDL)
preparation with polymorphonuclear leukocytes (open circles), activated polymorphonuclear leukocytes (filled circles),
copper ions (filled triangles), and control incubations without cells or copper ions (open triangles). Incubation conditions
are as described in Materials and Methods. Mean values of duplicate determinations from one experiment.
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Fig. 3. Superoxide anion production by polymorphonuclear
leukocytes (n = 5) in the presence and absence of
phorbol 12-myristate 13-acetate. Experimental condi-
tions as described in Materials and Methods.
vated polymorphonuclear leukocytes was accompa-
nied by an increased production of Superoxide anions
(fig. 3).
Modification of apolipoprotein B-100 by lipid per-
oxidation products was shown by agarose gel electro-
phoresis. Low density lipoprotein particles incubated
for 24 h in the presence of polymorphonuclear leu-
kocytes showed an increased negative charge com-
pared with native low density lipoprotein particles
incubated without cells (fig. 4). Furthermore, mac-
rophage degradation of low density lipoproteins mod-
ified by polymorphonuclear leukocytes was enhanced
(tab. 1). The accelerated lipid peroxidation achieved
by stimulation of the cells with phorbol 12-myristate
13-acetate also affected the degradation of these low
density lipoprotein particles by macrophages (tab. 1).
Aprotinin, which was added to prevent degradation
of apolipoprotein B-100 by proteases, had no effect
on the degradation of modified low density lipopro-
teins by macrophages (tab. 1).
Macrophage degradation of low density lipoproteins
modified by polymorphonuclear leukocytes was in-
hibited by a 10-fold excess of unlabelled acetyl- or
copper-modified low density lipoproteins. Unlabelled
acetylated low density lipoproteins and low density
lipoproteins oxidized by copper ions displaced 60%
and 80%, respectively, of the 125I-labelled low density
lipoproteins which had previously been incubated in
the presence of polymorphonuclear leukocytes for
24 h (fig. 5).
Fig. 4. Agarose gel electrophoresis of a low density lipoprotein
(LDL) preparation incubated for 24 h in the presence
of activated polymorphonuclear leukocytes (lane 1),
non-activated polymorphonuclear leukocytes (lane 2),
native LDL (lane 3), and LDL incubated without cells
(lane 4). Incubation conditions as described in Materials
and Methods.
The effect of various inhibitors and radical scavengers
on the oxidation of low density lipoproteins by poly-
morphonuclear leukocytes is shown in table 2. Ad-
dition of 30 kU/1 Superoxide dismutase resulted in a
marked inhibition of peroxidation of low density lipo-
protein lipids in both activated and non-activated
Tab. 1. Macrophage degradation of a low density lipoprotein
(LDL) preparation previously incubated in the presence
of polymorphonuclear leukocytes
Sample Degradation by
macrophages
(g/5 h · kg
cell protein)
LDL incubated in the absence of cells
LDL incubated in the presence
of CuSO4
LDL incubated in the presence
of CuSO4 and aprotinin
LDL incubated in the presence
of cells and aprotinin
LDL incubated in the presence
of activated cells plus aprotinin
7
5
0.30 ± 0.07
1.40 ± 0.11*
3 1.36 - 1.43*+
7 0.98 ± 0.23*
7 1.29 ± 0.35**
Values are means ± SD or range (+) from the indicated number
of experiments. For cell activation, phorbol 12-myristate 13-
acetate was used as described in Materials and Methods.
* Significantly different from low density lipoproteins incu-
bated in the absence of cells (p <: 0.05)
** Significantly different from low- density lipoproteins incu-
bated in the presence of cells and aprotinin without phorbol
myristate acetate (p < 0.05)
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Fig. 5. Macrophage degradation of a labelled low density lipoprotein preparation previously incubated in the presence of
polymorphomiclear leukocytes (125I-PMN-LDL). Displacement by unlabelled LDL incubated without cells (control LDL),
by unlabelled acetylated LDL, or by unlabelled LDL previously incubated in the presence of copper ions (CuSO4-LDL).
Experimental conditions as described in Materials and Methods. Mean values of duplicate determinations from one
experiment.
cells. Most of the inhibitory effect was abolished after
heating of the enzyme to 90 °C for 10 min. Similar
effects were observed with 40 μιηοΐ/ΐ of the non-
specific general antioxidant, butylated hydroxyto-
Tab. 2. Effect of different inhibitors on the oxidation of a low
density lipoprotein (LDL) preparation by polymorpho-
nuclear leukocytes.
Inhibitor added Thiobarbituric
acid-reactive materials
(Malondialdehyde,
mmol/kg LDL protein)
Cells
plus LDL
Activated
cells
plus LDL
No inhibitor 10.3
Butylated hydroxytoluene 1.6
(40 μιηοΐ/ΐ)
Superoxide dismutase 1.8
(30 kU/1)
Superoxide dismutase n. d.
(heat inactivated)
Catalase (110 kU/1) n.d.
Eicosatetraynoic acid 8.7
(20 μιηοΐ/ΐ)
Mannitol (25 mmol/1) 10.0
18.4
1.8
6.0
14.1
16.9
17.4
18.2
LDL incubated without
cells and without
inhibitor
2.2
Values are means of duplicate determinations from one repre-
sentative experiment. For cell activation, phorbol 12-myristate
13-acetate was used as described in Materials and Methods,
n.d. = not determined.
luene. The lipoxygenase inhibitor, eicosatetraynoic
acid, was without effect on the oxidation of low
density lipoproteins by human polymorphonuclear
leukocytes, as was catalase (110 kU/1) and the hy-
droxyl radical scavenger, mannitol (25 mmol/1).
Discussion
Oxidative modification of low density lipoproteins has
been implicated in the generation of macrophage-
derived foam cells (7 — 12), a hallmark of the early
atherosclerotic lesion (14, 24). Once the endothelial
lining of the vessel wall has been damaged, the pro-
gression of atherosclerosis can be considered as a
chronic inflammatory process (13).
Polymorphonuclear leukocytes are found in the sub-
endothelial space at sites of arterial damage in exper-
imental animals (13). These cells contain lipoxygenase
enzymes and release oxygen radicals upon encounter
with ail appropriate ligand (15, 19). They have been
shown to oxidize low density lipoprotein lipids, mak-
ing them cytotoxic (17), and to alter low density
lipoproteins by the action of elastase, resulting in their
increased uptake by macrophages via the classical low
density lipoprotein receptor (20). In contrast, our
results show that incubation of low density lipopro-
teins with human polymorphonuclear leukocytes
leads to oxidatively modified low density lipoproteins
which are recognized by the scavenger receptor of
macrophages. Scavenger receptor-mediated uptake of
modified low density lipoproteins must be considered
more important for the development of artheroscler-
Eur. J. Clin. Chem. Clin. Biochem. / Vol. 31,1993 / No. 11
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otic plaques in vivo, since monocytes lose most of
their low density lipoprotein receptor activity upon
transformation to macrophages, which then express
scavenger receptor activity (24). The observation that
low density lipoproteins modified by human poly-
morphonuclear leukocytes are displaced less effi-
ciently by acetylated low density lipoproteins than by
low density lipoproteins modified by copper ions,
confirms findings of Sparrow et al. concerning the
heterogeneity of the scavenger receptor with respect
to different ligands (28).
The present investigations strongly suggest a role of
Superoxide anions in the oxidative modification of
low density lipoproteins by polymorphonuclear leu-
kocytes and exclude a lipoxygenase-mediated oxida-
tion mechanism for the following reasons:
i) oxidation of low density lipoproteins was inhib-
ited by Superoxide dismutase
ii) eicosatetraynoic acid was without effect on the
oxidation of low density lipoproteins
iii) stimulation of Superoxide anion release increased
the modification of low density lipoproteins
Phorbol 12-myristate 13-acetate is a direct activator
of protein kinase C and therefore selectively stimulates
the formation of Superoxide anions. It bypasses the
activation of eicosanoid formation in human poly-
morphonuclear leukocytes (29).
This mechanism of low density lipoprotein modifi-
cation in polymorphonuclear leukocytes is in contrast
to macrophages and endothelial cells where 15-lipoxy-
genase activity has been suggested to be responsible
for the oxidative modification of low density lipopro-
teins (11, 12).
Abdalla et al. (18) reported peroxidation of low den-
sity lipoprotem lipids by polymorphonuclear leuko-
cytes activated with substances which are known to
increase leukotriene production (29). However, they
did not employ lipoxygenase inhibitors to exclude a
contribution of lipoxygenase enzymes to the modifi-
cation of low density lipoproteins by human poly-
morphonuclear leukocytes. The authors emphasized
the requirement for iron to initiate peroxidation of
low density lipoprotein lipids. In their system, how-
ever, containing activated polymorphonuclear leuko-
cytes and ferritin, they generated mainly lipid hydro-
peroxides, with only very small quantities of alde-
hydes which are required for the modification of the
apolipoprotein B-100 and therefore for foam cell for-
mation (9). We used the protocol originally published
by Henriksen et al. (30) to oxidize low density lipo-
proteins; this protocol uses the iron-containing Ham's
F-10 cell culture medium. With his approach we were
able to generate 10 times more malondialdehyde
equivalents than reported by Abdalla et al. (18). Since
catalase and mannitol did not influence the oxidative
modification of low density lipoproteins by polymor-
phonuclear leukocytes it is unlikely that other reactive
oxygen species such as hydrogen peroxide or hydroxyl
radicals contribute to the oxidation process.
Oxidation of low density lipoproteins by polymor-
phonuclear leukocytes was observed even in the ab-
sence of a stimulus. Nathan reported that the adhesion
of polymorphonuclear leukocytes to plastic surfaces
is sufficient to activate polymorphonuclear leukocytes
at a low rate (31). This is supported by the present
investigation using adherent cells for low density lip-
oprotein modification, which had already generated
Superoxide anions at a low rate in the absence of a
stimulus.
It is concluded that an increase in the release of
Superoxide anion from polymorphonuclear leuko-
cytes, as may occur at lesion sites in vivo, can accel-
erate oxidative modification of low density lipopro-
teins. Possible activators in vivo are immune com-
plexes (32). Autoantibodies directed against oxida-
tively modified low density lipoproteins have recently
been reported in vivo (33). Therefore, polymorpho-
nuclear leukocytes may contribute to foam cell for-
mation in vivo as do other cells found in atheroscle-
rotic lesions, such äs endothelial cells, macrophages,
smooth muscle cells, and monocytes.
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